EX-32 3 c53138aexv32.htm EX-32 EX-32
         
Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned Chief Executive Officer and Chief Financial Officer of CytoCore, Inc. (the “Company”) certifies that, to his knowledge:
1. The Company’s Form 10-Q for the quarter ended June 30, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
     
  /s/ Robert F. McCullough, Jr.   
  Robert F. McCullough, Jr.
Chief Executive Officer and
Chief Financial Officer
Dated: August 19, 2009